24Antimicrobial resistance is widespread in Salmonella infections that affect millions 25 worldwide. Salmonella typhi and other Gram-negative bacterial pathogens encode an outer 26 membrane phospholipase A (OmpLA), crucial for their membrane integrity. Further, OmpLA 27 is implicated in pathogen internalization, haemolysis, acid tolerance, virulence and sustained 28 infection in human hosts. OmpLA is an attractive drug target for developing novel anti-29 microbials that attenuate virulence, as the abrogation of OmpLA encoding pldA gene causes 30 loss of virulence. Here, we present the crystal structure of Salmonella typhi OmpLA in 31 dimeric calcium bound activated state at 2.95 Å. Structure analysis suggests that OmpLA is a 32 potential druggable target. Further, we have identified and shortlisted small molecules that 33 bind at the dimer interface using structure based in silico screening, docking and molecular 34 dynamics. While it requires further experimental validation, anti-microbial discovery 35 targeting OmpLA from gram-negative pathogens offers an advantage as OmpLA is required 36 for virulence. 37 38 Keywords: Outer membrane phospholipase A (OmpLA), OmpLA, Salmonella typhi, crystal 39 structure, antibiotic resistance, antimicrobial design 40 41 42 43 44 65 strongly suggests OmpLA is not essential for growth but is a major virulence factor and 66 hence a potential drug target. Interestingly, bacterial OmpLA shows no sequence or structural 67 homology with soluble phospholipases in human, indicative of its usefulness as a unique drug 68 target. 69 4 70 Results and discussion 71 Structure determination of S. typhi OmpLA 72S. typhi OmpLA (StOmpLA), cloned without the signal sequence ( Fig. S1a, b), was 73 overexpressed in E. coli as inclusion bodies. Scouting urea concentration for unfolding 74 OmpLA shows sharp rise in absorption at OD280 at 4 M which stabilizes at 6 M ( Fig. S1c, d).
75Large-scale unfolding was done using 8 M urea, and refolding was achieved in presence of 76 0.3% Polyoxyethylene (9) lauryl ether (C12E9). Refolded OmpLA was further purified using 77 ion-exchange and size exclusion chromatography ( Fig. S1e, f) and concentrated to 14 mg/ml.
78Then the protein was detergent exchanged from C12E9 to β-octyl-glucoside (β-OG) using an 79 ion-exchange column, concentrated to 14 mg/ml, flash frozen in liquid nitrogen and stored at 80 -80 ºC before crystallization. Total yield of refolded and detergent exchanged OmpLA was 81 15 mg/gm of purified inclusion bodies. Circular dichroism (CD) data (Fig. S1g), using a 240 82 to 205 nm scan, shows minimum mean residue molecular ellipticity [Ɵ] (MRW) around 217 83 nm and a crossover at 210 nm, indicating refolded OmpLA contains mainly of β-structure, 84 similar to EcOmpLA 11,12,13 . Protocol described here (Methods) yields more refolded OmpLA 85 than previously published methods 14,15 . Refolded OmpLA was crystallized in various 86 conditions using MemGold 1 and 2. Diffraction quality crystals (Fig. S1h) were obtained in a 87 condition containing 0.1 ...